Literature DB >> 849655

The spectrum of human tuberculosis.

L Lenzini, P Rottoli, L Rottoli.   

Abstract

Clinical, morphological and immunological studies of human tuberculosis have enabled the spectrum of the disease to be determined. We have investigated the cell-mediated immune responses by means of skin tests and leucocyte migration inhibition to PPD, and the humoral immune responses by means of immunodiffusion and haemagglutination tests. Patients with tuberculosis can be classified into two polar groups--reactive (RR) and unreactive (UU), the former showing good cell-mediated immunity and little or no antibody formation and the latter poor cellular responses and exuberant antibody production. The intermediate forms show characteristics of the neighbouring polar groups. The existence of a spectrum of immune response in tuberculosis, which has long been suspected, is now demonstrated.

Entities:  

Mesh:

Year:  1977        PMID: 849655      PMCID: PMC1540785     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  8 in total

1.  Importance of thymus-derived lymphocytes in cell-mediated immunity to infection.

Authors:  R J North
Journal:  Cell Immunol       Date:  1973-04       Impact factor: 4.868

2.  The nature of changes in the cellular infiltration during two weeks after tuberculin testing in patients with active tuberculosis.

Authors:  L Lenzini; R Barnabé
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

3.  [Anti-PPD free circulating antibodies in tubercular infection and disease].

Authors:  L Lenzini; P Rottoli; L Rottoli; S Sestini
Journal:  Boll Soc Ital Biol Sper       Date:  1974-02-15

4.  Immune response to Mycobacterium tuberculosis in rats.

Authors:  M J Lefford; D D McGregor; G B Mackaness
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

5.  [Inhibition of leukocyte migration in tuberculosis and diseases with cutaneous energy].

Authors:  L Lenzini; L Rottoli; P Rottoli
Journal:  Ann Sclavo       Date:  1974 Jan-Feb

Review 6.  The immunology of antituberculous immunity.

Authors:  G B Mackaness
Journal:  Am Rev Respir Dis       Date:  1968-03

7.  Migration inhibition studies in human disease.

Authors:  J Brostoff
Journal:  Proc R Soc Med       Date:  1970-09

Review 8.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

  8 in total
  57 in total

1.  Mycobacterium paratuberculosis antigen D: characterization and evidence that it is a bacterioferritin.

Authors:  B W Brooks; N M Young; D C Watson; R H Robertson; E A Sugden; K H Nielsen; S A Becker
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 2.  Heterogeneity in tuberculosis.

Authors:  Anthony M Cadena; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Rev Immunol       Date:  2017-07-24       Impact factor: 53.106

3.  Generalised non-reactive tuberculosis: a clinicopathological study of four patients.

Authors:  R Singh; R C Joshi; J Christie
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

4.  Repeated delayed-type hypersensitivity reactions against Mycobacterium lepraemurium antigens at the infection site do not affect bacillary multiplication in C3H mice.

Authors:  M Løvik; O Closs
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

5.  Passive transfer of tuberculin sensitivity from anergic mice.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

6.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Hemolysin-producing Listeria monocytogenes affects the immune response to T-cell-dependent and T-cell-independent antigens.

Authors:  C M Hage-Chahine; G Del Giudice; P H Lambert; J C Pechere
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Development of delayed hypersensitivity responses in Mycobacterium lepraemurium infections in resistant and susceptible strains of mice.

Authors:  J Alexander; J Curtis
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

9.  Effect of cyclophosphamide treatment on the course of Mycobacterium lepraemurium infection and development of delayed-type hypersensitivity reactions in C57B1 and BALB/c mice.

Authors:  J Alexander
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

10.  The role of macrophages in the lymphoproliferative response to Mycobacterium leprae in vitro.

Authors:  H Hirschberg
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.